International hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions

Matrix Biology

Volumn 23, Issue 1, 2004, Pages 63-69

  Bos, T J ^a   Cohn, S L ^b   Kleinman, H K ^c   Koblinski, J ^c   Murphy Ullrich, J E ^d   Podhajcer, O L ^e   Rempel, S A ^f   Rich, J N ^g   Rutka, J T ^h   Sage, E H ⁱ   Thompson, E W ^j  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^f HENRY FORD HOSPITAL   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ HOPE HEART INSTITUTE   (United States)

^j UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; OSTEONECTIN;

ANAPLASTIC CARCINOMA; ASTROCYTOMA; BRAIN TUMOR; CANCER CELL; CANCER GRADING; CANCER INVASION; CANCER THERAPY; CELL INTERACTION; CLINICAL RESEARCH; CONFERENCE PAPER; CONTINUING EDUCATION; DNA SYNTHESIS; EPENDYMOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; MALIGNANT TRANSFORMATION; MEDICAL EXPERT; MEDICAL INFORMATION; MICROENVIRONMENT; MITOSIS INHIBITION; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TISSUE SECTION;

ANIMALS; BRAIN NEOPLASMS; CELL ADHESION; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; OSTEONECTIN;

EID: 2542474040     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2004.01.002     Document Type: Conference Paper

References (18)

1. Alvarado C.S., London W.B., Look A.T., Brodeur G.M., Altmiller D.H., Thorner P.S., et al. Natural history and biology of stage A neuroblastoma: a pediatric oncology group study. J. Pediatr. Hematol. Oncol. 22:2000;197-205
2. Bradshaw A.D., Sage E.H. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J. Clin. Invest. 107:2001;1049-1054
3. Briggs J., Chamboredon S., Castellazzi M.J., Bos T.J. Transcriptional upregulation of SPARC, contributes to increased motility and invasion induced in response to c-Jun overexpression in MCF7 breast cancer cells. Oncogene. 21:2002;7077-7091
4. Chlenski A., Liu S., Crawford S.E., Volpert O.V., DeVries G.H., Evangelista A., et al. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Res. 62:2002;7357-7363
5. De D., Chen J., Narizhneva V.N., Heslin W., Brainard J., Sage E.H., et al. Molecular pathway for cancer metastasis to bone. J. Biol. Chem. 278:2003;39 044-39 050
6. Dhanesuan N., Sharp J.A., Blick T., Price J.T., Thompson E.W. Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition. Breast Cancer Res. Treat. 75:2002;73-85
7. Gilles C., Bassuk J.A., Pulyaeva H., Sage E.H., Foidart J.M., Thompson E.W. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res. 58:1998;5529-5536
8. Jacob K., Webber M., Benayahu D., Kleinman H.K. Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. Cancer Res. 59:1999;4453-4457
9. Kleihues, P., Louis, D.N., Scheithauer, B.W., Rorke, L.B., Reifenberger, G., Burger, P.C., et al. 2002, The WHO classification of tumors of the nervous system., J. Neuropathol. Exp
10. Ledda F., Bravo A.I., Adris S., Bover L., Mordoh J., Podhajcer O.L. The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J. Invest. Dermatol. 108:1997;210-214
11. Ledda M.F., Adris S., Bravo A.I., Kairiyama C., Bover L., Chernajovsky Y., et al. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nature Med. 3:1997;171-176
12. Murphy-Ullrich J.E. The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J. Clin. Invest. 107:2001;785-790
13. Rempel S.A., Golembieski W.A., Ge S., Lemke N., Elisevich K., Mikkelsen T., et al. SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. J. Neuropathol. Exp. Neurol. 57:1998;1112-1121
14. Rich J.N., Shi Q., Hjelmeland M., Cummings T.J., Kuan C.-T., Bigner D.D., et al. Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J. Biol. Chem. 278:2003;15951-15957
15. Rinehart-Kim J., Johnston M., Birrer M., Bos T.J. Alterations in the gene expression profile of MCF-7 breast cells in response to c-Jun. Int. J. Cancer. 88:2000;180-190
16. Schultz C., Lemke N., Ge S., Golembieski W.A., Rempel S.A. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. Cancer Res. 62:2002;6270-6277
17. Smith L.M., Wise S.C., Hendricks D.T., Sabichi A.L., Bos T.J., Reddy P., et al. cJun overexpression in MCF-7 breast tumor cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene. 18:1999;6063-6070
18. Termine J.D., Kleinman H.K., Witson S.W., Conn K.M., McGarvey M.L., Martin G.R. Osteonectin, a bone-specific protein linking mineral to collagen. Cell. 26:1981;99-105